Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

Abroad (travel likely)RecruitingPHASE3

Conditions

Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China

  • Huashan Hospital of Fudan University, Shanghai, Province, China

    Contact: Study coordinator (Jintai Yu, M.D.) · jintai_yu@fudan.edu.cn · 021-52889999